Myovant Sciences and Accord Healthcare enter into exclusive licence agreement to commercialise… EP News Bureau May 13, 2022 Myovant to receive an upfront payment of $50 million, is eligible to receive commercial launch, sales-based and other milestones…
UK fines pharma companies $360 million for overcharging NHS Reuters Jul 15, 2021 The watchdog said the firms charged the NHS "excessively high prices" for almost a decade for the steroid hydrocortison
Intas Pharmaceuticals launches biosimilar in Europe Usha Sharma Feb 23, 2015 The product has recently been introduced under the brand Accofil and has already won two tenders, in Netherlands and the UK
